Related Experiment Video
Updated: Jul 11, 2026
09:39
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
Varying polymer architecture to deliver drugs
Felicity Heath1, Prinal Haria, Cameron Alexander
1School of Pharmacy, Boots Science Building, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
The AAPS Journal
|October 3, 2007
Summary
Variable architecture polymers offer a promising alternative to biopolymers for drug delivery. These smart polymers respond to stimuli like temperature and pH, enhancing targeted delivery and reducing immune responses.
Area of Science:
- Polymer chemistry and materials science
- Biomedical engineering
- Nanotechnology for drug delivery
Background:
- Therapeutic biopolymers (DNA, proteins) face challenges like immune responses and delivery inefficiencies.
- Viruses utilize environmental cues for cellular entry, offering a model for synthetic systems.
- Synthetic polymers provide a tunable and potentially less immunogenic alternative for drug delivery vehicles.
Purpose of the Study:
- To review recent advancements in variable architecture polymers for therapeutic biopolymer delivery.
- To focus on polymers responsive to temperature and pH stimuli.
- To highlight polymers with properties crucial for effective drug delivery vehicles.
Main Methods:
- Review of recently developed variable architecture polymers.
- Focus on synthetic copolymers and naturally derived polymer derivatives.
- Analysis of polymers responsive to temperature and pH stimuli.
Main Results:
- Variable architecture polymers demonstrate tunable responses to environmental stimuli.
- Both synthetic and naturally derived polymers show potential for advanced drug delivery.
- Key properties like biodegradability, specificity, and biocompatibility are discussed.
Conclusions:
- Variable architecture polymers are highly promising for advanced drug delivery applications.
- Stimuli-responsive polymers can improve targeted delivery and reduce adverse effects.
- Further development of these polymers is crucial for effective therapeutic biopolymer delivery.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:14Polymer Classification: Architecture
Polymers are classified as linear or branched on the basis of their chain architecture. The polymer chains in linear polymers have a long chain-like structure with minimal to no branching at all. Even if a polymer features large substituent groups on the monomer, which appear as branches to the skeleton, it is not considered a branched polymer. A branched polymer contains secondary polymer chains that arise from the main polymer chain. The branching occurs when the polymer growth shifts from...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.